Filing Details

Accession Number:
0001127602-12-019282
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-05 15:45:15
Reporting Period:
2012-06-04
Filing Date:
2012-06-05
Accepted Time:
2012-06-05 15:45:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236188 W Robert Pangia Biogen Idec Inc.
133 Boston Post Road
Weston MA 02493
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-04 5,000 $36.94 21,578 No 4 M Direct
Common Stock Disposition 2012-06-04 5,000 $130.00 16,578 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2012-06-04 5,000 $0.00 5,000 $36.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2004-01-02 2014-01-01 No 4 M Direct
Footnotes
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Granted under Issuer's 1993 Non-Employee Director's Stock Option Plan in a transaction exempt under 16(b)3(d).
  3. Immediately exercisable for all the option shares on 1/2/2004 subject to Issuer's repurchase rights which lapse on 1/2/2005.